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Abstract 
The paper reports the results of the studies carried out by us on the changes in the phototoxicity of some hydrophilic (Chlorin-p6, 
Merocyanine 540, Rose Bengal) and hydrophobic photosensitisers (Curcumin) in presence of silica nanoparticles (NP).  The 
electrostatically bound complexes of these hydrophilic photosensitisers obtained by simple mixing of PS and NP exhibited 
enhanced toxicity compared to the free PS. While for Chlorin-p6, the increased photostability of the Cp6-NP complex was found 
to be the main contributor for the enhanced toxicity, in case of Rose Bengal, the cellular uptake of the complex was larger as 
compared to free drug and in Merocyanine 540 a reduction in the photoisomerization rate was the main factor responsible for 
increased phototoxicity. Further, whereas, the covalently bound complexes of NP with Rose Bengal and Chlorin-p6 showed 
higher cellular uptake, these tended to aggregate over a period of time. Addition of NP to a solution of Curcumin was observed to 
reduce the hydrolysis of Curcumin and compared to free Curcumin, the NP-Curcumin complex was observed to result in higher 
uptake and phototoxicity in oral carcinoma cells and tumor spheroids. 
© 2013 The Authors. Published by Elsevier Ltd.  
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1. Introduction 
Successful use of Photodynamic Therapy (PDT) for the treatment of cancer poses two main requirements. First, a 
preferential localization of the photosensitiser (PS) in tumor and second a high yield of reactive oxygen species on 
photoexcitation. There has been interest in the use of metallic and dielectric nanoparticles to enhance the efficacy of 
PDT by improving these aspects. Complexion with a suitable nanoparticle platform is of particular interest for the 
utilization of potentially attractive drugs which could not be used because of poor solubility or stability [1-5]. 
Similarly, magnetic and metal nano particles (NP) can also help simultaneous PDT & hyperthermia. For all these 
applications it is essential to study how the photophysical or photochemical properties of the drug are affected when 
it forms a complex with nanoparticles.  
In this paper we present an overview of the results of the studies carried out by us on the changes in the 
photophysical or photochemical properties of some photosensitisers when these interact with silica nanoparticles. 
Results of studies carried out on the phototoxicity of the free drug and its complexes with silica NP are also 
presented. 
© 2013 P.K. Gupta. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
Selection and/or peer-review under responsibility of the scientific committee of Symposium [Symposium BB - Nanomedicine: Emerging 
Nanomaterials for Bioimaging, Targeting and Therapeutic Applications] – ICMAT
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1.1. Silica nanoparticles 
Silica nanoparticles are receiving attention as delivery vehicle for photosensitisers because these offer several 
advantages like ease of preparation with desired purity, biocompatibility, porosity and transparency over the 
therapeutic spectral range (600-900 nm). The hydrophilic nature of these NPs reduces their non-specific binding 
with proteins and other macromolecules present in biological fluids.  Further, the Organically Modified Silica 
(ORMOSIL) nanoparticles having the Vinyl and 3-amino propyl functional groups are easy to functionalize.  
The ORMOSIL nanoparticles were synthesized at room temperature in the nonpolar core of Aerosol-OT (AOT) »
1-butanol »ZDWHUPLFHOODUV\VWHPIROORZLQJSURFHGXUHGHVFULEHGHDUOLHU>@%ULHIO\WKHPLFHOOHVZHUHSUHSDUHGE\
dissolving AOT (0.44 gm) and 1-butanol (0.8 mL) in water (20 mL) by vigorous magnetic stirring. Vinyl-
triethoxysilane (0.3 mL) was added to the micellar system and the resulting system was stirred for about 1 h until the 
solution becomes clear. After this 3-aminopropyl-trimethoxysilane (0.02 mL) was added and stirred for about 20 h 
till the solution turned bluish white. This indicated formation of nanoparticles. Unreacted AOT and 1-butanol were 
removed by dialysis for about 48 h using a cellulose membrane (cut off 20 kDa).  Transmission electron microscopy 
and dynamic light scattering measurements showed that the particles had a mean diameter of ~  30 nm with a 
polydispersity of ~  0.16. At neutral pH the particles were negatively charged (zeta potential ~ -45 mV) and had 
positively charged amino groups since the pKa of 3-amino propyl group is ~ 9.2. The positive charge on 3-amino 
propyl groups can form electrostatic complex with PS having negatively charged functional groups and can also be 
used for covalent coupling with other molecules having carboxylic acid groups (via forming amide bonds).  
2. Interaction of silica NPs with different PS 
2.1. Interaction  with Merocyanine 540 (MC540) 
MC540 is an anionic lipophilic dye which readily binds to membranes, macromolecules and organized 
assemblies [7]. While it has been used for several photodynamic applications like blood sterilization, purging of 
bone marrow, etc [8], its use gets limited because of its rather low singlet oxygen yield, poor photostability and 
tendency to aggregate in aqueous solution. The relatively low singlet oxygen (1O2) quantum yield of the dye arises 
due to an efficient excited state photoisomerization around the central double bond, the main non-radiative decay 
pathway for MC540 in the excited state [7]. The radical species generated during the photoisomerization process are 
believed to be responsible for the photodegradation of the dye. It has been reported earlier that inhibition of 
photoisomerization on binding with liposome leads to significant enhancement in 1O2 yield (by a factor of 20) and 
also leads to improved photostability [9]. Since the SO3- group of MC540 has a negative charge it can 
electrostatically bind the drug with 3-amino propyl groups of ORMOSIL nanoparticles. This motivated us to 
investigate if binding of MC540 with ORMOSIL nanoparticles can be used to inhibit photoisomerization and thus 
improve phototoxicity of the dye.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: a): Fluorescence spectra (Ȝex = 530 nm) of MC540 in aqueous medium without (black curve) and in presence of NP (red curve) 
 
In Figure 1 (a) we show the fluorescence of MC 540 in aqueous medium without and with the addition of 
ORMOSOL nanoparticles. The significant enhancement of fluorescence yield in presence of NP suggests that there 
is a strong interaction between the dye and NP and that it leads to a reduction in the photoisomerization.  This is 
likely to result due to the restriction on the intramolecular motion of the dye bound at the NP surface.   
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Figure 2: Photobleaching of MC540 in aqueous medium in the absence (a) and in the presence of NP (b). The arrow represents increasing 
light dose of 0, 1.8, 3.6 and 5.4 kJ/m2. NP concentration = ~940 μg/mL. In presence of NPs the absorption spectra at all light doses are 
overlapping indicating a large enhancement in the photostability of MC540. 
 
The change in absorption spectra of MC 540 in aqueous medium without and with the addition of ORMOSOL NPs 
with an increase in visible light irradiation is shown in Figure 2 (a) and (b) respectively. A significant improvement 
in photostability of the PS in presence of NP is evident consistent with the expected reduction in photoisomerization 
rate.   
 
 
 
 
 
 
 
 
 
 
Figure 3: Light induced toxicity of MC540 (1 μM), NP (20 μg/mL) and MC540-NP complex against MCF-7 cells. 
 
In Figure 3 we show the results of phototoxicity measurements carried out on MCF-7 cells using MC540 and its 
electrostatic complex with ORMOSIL NP. For the PS-nanoparticle complex the light dose dependent cell killing 
was observed to be significantly higher compared to that for free PS and NP [10]. This is consistent with the 
expected increase in singlet oxygen yield due to a reduction in the photoisomerization rate.  
 
2.2. Interaction  with Rose Bengal (RB) 
RB, an anionic PS has a good singlet oxygen (1O2) yield [11] but suffers from a poor intracellular uptake due to 
its hydrophilic nature. Binding of RB with ORMOSIL NP can be used to enhance its uptake by exploiting the EPR 
(Enhanced Permeability and Retention) effect [12].  Both electrostatic as well as covalent complex of RB with 
ORMOSIL NP were prepared. Since RB has a carboxyl group which is negatively charged at physiological pH the 
electrostatic complex can be made by simple mixing of the PS and NP solution. The covalent complex was prepared 
by coupling the carboxyl group of RB with the 3-amino propyl groups present in NP by the well known EDC-NHS 
method. The sizes and the zeta potential values of the NP,the RB-NP electrostatic and covalent complex were found 
to be similar (~ 35-50 nm and ~ -34 mV) indicating that complexation of the PS with NP did not affect the surface 
charge of the particles. The covalent binding of RB with ORMOSIL NP was confirmed by the red shift (from 1614 
cm-1 to 1653 cm-1) of the carbonyl stretching vibration in the FTIR spectra of the complex [13]. The phototoxicity of 
the PS-NP complex and the free PS was studied using oral (4451) and breast (MCF-7) cancer cell lines. The results 
for the latter are shown in Figure 4.  
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Figure 4: Cytotoxicity of RB and its NP
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Figure 5: Different ionic structures of Cp6 possible in the pH range of 3-8 
 
In aqueous medium at physiological pH the drug exists predominantly as negatively charged (i.e. closer to structure 
D in Figure 5) and as the pH is progressively lowered, successive protonation of the carboxyl groups (forming 
structures C to A in Scheme 1) makes it hydrophobic leading to aggregation of the drug which has been shown to 
enhance its uptake in human colon adenocarcinoma (Colo-205) cells [19]. The change in acid/base ionization 
equilibrium of the PS also leads to significant changes in its absorption and fluorescence characteristics.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Absorption (top panel) & emission (bottom panel) spectra of Cp6 in the absence (left) and in the presence (right) of NP (940 μg/mL) at 
different pH. The arrow in each panel represents pH increasing from 3 to 8 in steps of unity. Although the spectra are shown in same Y-axis 
scale, they are shifted vertically for clarity. 
 
In Figure 6 we show the absorption and fluorescence spectrum of Cp6 as a function of pH, both without and in 
presence of ORMOSIL NP.  The significant reduction in the quenching of absorbance (around 640-660 nm) and 
fluorescence (around 630-680 nm) with decreasing pH suggests a strong electrostatic interaction between the PS and 
NP which prevents formation of hydrophobic aggregates of the PS.  
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Figure 7: Changes in percent cell survival following PS treatment in dark and after exposure to light for Colo-205 and Nt8e cells. 
 
In Figure 7 we show the viability of Colo-205 and NT8e cells, incubated for 3 h with free PS or its NP complex, in 
dark and on exposure to red light. The figure also shows data on the cell viability of a control sample that received 
neither the drug nor the light. While the dark toxicity of free Cp6 alone (10 μM) was around 15% the Cp6-NP 
complex (10 μM drug and 200 μg/ml NP) had higher (~ 30%) dark toxicity presumably due to the toxicity of NPs.   
Further, on irradiation with light (dose ~ 20 kJ/m2) a much larger decrease in cell viability (~85%) was observed for 
Cp6-NP complex in comparison with free Cp6 (~ 40 %).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: (a) Cellular uptake of Cp6 as relative fluorescence intensity in intact cells and after extraction in SDS:NaOH solution; (b) Relative 1O2 
yield from 10 ȝM Cp6 (solid, black) and 10 ȝM Cp6-200 ȝg/ml NP complex (hollow, red) under irradiation at 660 ± 20 nm compared by 
monitoring the decrease in the OD of RNO at 440 nm; (c) Photobleaching of 10 ȝM Cp6 (black) and 10 ȝM Cp6-200 ȝg/ml NP complex (red) in 
10% serum media under irradiation at 660 ± 20 nm. The kinetics was followed by monitoring the decrease in the OD of the Soret band of Cp6. 
 
Measurements made on the intracellular uptake of Cp6 and its NP complex in Colo-205 and Nt8e cells (Figure 8a) 
showed no significant difference in relative amount of free Cp6 and its NP complex in the cells. The 1O2 generation 
yield for the free PS and PS-nanoparticle complex measured by the light dose dependent decrease in the OD (at 440 
nm) of RNO is shown in Figure 8b. For both the cases the rate of photobleaching of RNO is similar suggesting that 
1O2 generation of the drug is not affected by binding with nanoparticles. The photostability of the drug and its 
complex with nanoparticles was monitored by measuring the changes in Soret band absorbance of the free drug and 
its NP complex after exposure to red light.  These experiments were done in aqueous as well as serum (10%) media. 
The plot of change in absorbance (in log scale) of the drug vs. irradiation time is shown in Figure 8c. In aqueous 
medium both with and without serum, the photostability of the drug increased significantly when NP was present. 
The results show that the complex of Cp6 with NPs produced higher phototoxic effect on colon carcinoma and oral 
carcinoma cells as compared to free Cp6. The intracellular uptake of the drug and the rate of singlet oxygen 
generation when compared for free Cp6 and Cp6-NP complex showed no difference. The binding of Cp6 with NP 
was seen to improve its photostability which could be the main reason for the observed increase in the phototoxicity 
of Cp6-NP. 
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2.4. Interaction with Curcumin 
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Figure 10: Viability of cells treated with 25 μM free curcumin and equivalent concentration of curcumin-NP complex for 1 and 4h in dark and 
then exposed to light. Viability of cells after different treatments was compared with untreated controls. 
 
Cytotoxicity induced by free curcumin and its complex with NP (25 μM) in 4451cells was studied after 1 and 4h 
incubation in dark and subsequent to exposure of these of cells to visible light (Figure 10). As compared to free 
curcumin phototoxicity of curcumin complexed with NP, was about ~ 2.1 times higher after exposure to light (dose 
12 J/cm2). With an increase in incubation time, dark toxicity and phototoxicity increased significantly in cells treated 
with curcumin-NP complex. Fluorescence microscopic study of cells incubated for 4 h with free curcumin or its NP 
complex showed a loss of  viability of ~3% and ~15% respectively (Figure 11, Left: upper panel). Exposure to light 
(20 J/cm2) after 4h of incubation with free curcumin or its NP complex showed ~20% and ~70%  loss of viability 
respectively (Figure 11, right upper & lower panels). Phase contrast images showed that photodynamic treatment led 
to extensive morphological alterations in both free curcumin and curcumin-NP treated cells which is suggestive of 
necrotic cell death due to membrane damage (Figure 11, right panels). These results are consistent with the 
expectation that higher uptake of curcumin in cells incubated with nanoformulation will result in an increase in the 
formation of superoxide and curcumin radicals in dark and formation of highly reactive singlet oxygen on exposure 
to light [33]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Fluorescence images of 4451 cells stained with Live cell indicator (calecin- green fluorescence)/Dead cell indicator (Propidium 
Iodide- red fluorescence) and their corresponding Phase contrast  images  incubated  with 25 μM of free curcumin and its NP complex. 
 
Studies carried out on the expression of NF-kB, a transcription factor and its related genes products involved in 
inflammation (TNF-Į), tumor metastasis (MMP-9) and angiogenisis (VEGF) showed that both in dark as well as on 
exposure to light (20 J/cm2) a much larger inhibition of these was observed in cells pretreated with curcumin–NP 
complex as compared to that for free curcumin (25 μM). This is consistent with the larger uptake of curcumin with 
the use of its nano-formulation.   
We have also investigated the photodynamic efficacy of curcumin delivered through NP in three dimensional cell 
cultures (tumor spheroids) of squamous cell carcinoma cells derived from upper aerodigestive tract (Nt8e). The 
tumor spheroids were prepared by using the hanging drop method [34]. This study was motivated by the fact that 
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monolayer cellular cultures are known to poorly mimic in-vivo conditions because these cannot account for several 
factors present in 3-D structure of tumor like heterogeneity in cells, presence of extracellular matrix,  existence of 
gradients in concentration of oxygen, nutrient, or pH.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Uptake of curcumin in spheroids incubated for 96h with different concentration of free curcumin and its NP complex containing 
equivalent concentration of curcumin  
 
Studies carried out on the uptake of curcumin in tumor spheroids showed significantly larger uptake for 
nanoformulation as compared to the free drug (Figure 12). This led to significant enhancement in dark toxicity. 
Photo irradiation of spheroids incubated with nanoformulation of curcumin (25 μM) for short period (24h) was 
observed to result in higher cell death (~80%), as compared to free curcumin (~40%).   
2.5. Conclusion 
The results presented in the paper show that electrostatic or covalent binding of photosensitisers with Silica 
nanoparticles can significantly affect their photo physical characteristics and thus affect their cellular uptake or 
singlet oxygen yield. Studies on MC540 showed a significant reduction in photoisomerism in presence of 
ORMOSIL NP and that it leads to enhanced singlet oxygen yield. For hydrophilic RB, both electrostatic and 
covalent binding with ORMOSIL NPs led to significant enhancement in cellular uptake and this was seen to be 
responsible for the observed higher phototoxicity. In case of Cp6, interaction with ORMOSIL NP was seen to affect 
its acid base ionization equilibrium and result in higher photo stability which appeared to be the main reason for the 
observed enhancement in phototoxicity. ORMOSIL NP post loaded with Curcumin was able to result in higher 
delivery of Curcumin in oral cancer cells as well as tumor spheroids resulting in higher therapeutic efficacy. 
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